abstract |
Use of a pectin hydrolysis product with a percentage of galacturonides, which contain at least one molecule of 4,5-unsaturated galacturonic acid and have been esterified up to 20% with methanol, for the manufacture of a pharmaceutical or dietary preparation for the prophylaxis and therapy of infectious diseases, intoxications or allergies. |